FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308708682> ?p ?o ?g. }

• W4308708682 endingPage "2022" @default.
• W4308708682 startingPage "00456" @default.
• W4308708682 abstract "Further understanding of when to initiate therapies in pulmonary arterial hypertension (PAH) is important to improve long-term outcomes. Post hoc analyses of GRIPHON (NCT01106014) and exploratory analyses of TRITON (NCT02558231) suggested benefit of early selexipag initiation on long-term outcomes, despite no additional benefit versus initial double combination on haemodynamic and functional parameters in TRITON. Post hoc analyses investigated the effect of early selexipag initiation on disease progression and survival in a large, pooled PAH cohort. Data from newly diagnosed (≤6 months) PAH patients from GRIPHON and TRITON were pooled. Patients on active therapy with selexipag (pooled selexipag group) were compared with those on control therapy with placebo (pooled control group). Disease progression end-points were defined as per the individual studies. Hazard ratios (HR) and 95% CI for time to first disease progression event up to end of double-blind treatment (selexipag/placebo) +7 days and time to all-cause death up to end of study were estimated using Cox regression models. The pooled dataset comprised 649 patients, with 44% on double background therapy. Selexipag reduced the risk of disease progression by 52% versus control (HR: 0.48; 95% CI: 0.35-0.66). HR for risk of all-cause death was 0.70 (95% CI: 0.46-1.10) for the pooled selexipag versus control group. Sensitivity analyses accounting for the impact of PAH background therapy showed consistent results, confirming the appropriateness of data pooling. These post hoc, pooled analyses build on previous insights, further supporting selexipag use within 6 months of diagnosis, including as part of triple therapy, to delay disease progression." @default.
• W4308708682 created "2022-11-14" @default.
• W4308708682 creator A5020503955 @default.
• W4308708682 creator A5025457428 @default.
• W4308708682 creator A5026902884 @default.
• W4308708682 creator A5031477165 @default.
• W4308708682 creator A5032928336 @default.
• W4308708682 creator A5033758604 @default.
• W4308708682 creator A5056570032 @default.
• W4308708682 creator A5060347511 @default.
• W4308708682 creator A5065469571 @default.
• W4308708682 creator A5068539599 @default.
• W4308708682 creator A5070548054 @default.
• W4308708682 creator A5077085879 @default.
• W4308708682 creator A5077135547 @default.
• W4308708682 creator A5077212270 @default.
• W4308708682 creator A5089685016 @default.
• W4308708682 date "2022-11-10" @default.
• W4308708682 modified "2023-10-14" @default.
• W4308708682 title "Early selexipag initiation and long-term outcomes: insights from randomised controlled trials in pulmonary arterial hypertension" @default.
• W4308708682 cites W1999594706 @default.
• W4308708682 cites W2112229901 @default.
• W4308708682 cites W2142655452 @default.
• W4308708682 cites W2146177859 @default.
• W4308708682 cites W2158862125 @default.
• W4308708682 cites W2278696749 @default.
• W4308708682 cites W2307535985 @default.
• W4308708682 cites W2607069020 @default.
• W4308708682 cites W2777572536 @default.
• W4308708682 cites W2904385559 @default.
• W4308708682 cites W2905582258 @default.
• W4308708682 cites W2989869936 @default.
• W4308708682 cites W3118615836 @default.
• W4308708682 cites W3126829642 @default.
• W4308708682 cites W3201735854 @default.
• W4308708682 cites W4293207258 @default.
• W4308708682 cites W4293217384 @default.
• W4308708682 doi "https://doi.org/10.1183/23120541.00456-2022" @default.
• W4308708682 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36687361" @default.
• W4308708682 hasPublicationYear "2022" @default.
• W4308708682 type Work @default.
• W4308708682 citedByCount "3" @default.
• W4308708682 countsByYear W43087086822023 @default.
• W4308708682 crossrefType "journal-article" @default.
• W4308708682 hasAuthorship W4308708682A5020503955 @default.
• W4308708682 hasAuthorship W4308708682A5025457428 @default.
• W4308708682 hasAuthorship W4308708682A5026902884 @default.
• W4308708682 hasAuthorship W4308708682A5031477165 @default.
• W4308708682 hasAuthorship W4308708682A5032928336 @default.
• W4308708682 hasAuthorship W4308708682A5033758604 @default.
• W4308708682 hasAuthorship W4308708682A5056570032 @default.
• W4308708682 hasAuthorship W4308708682A5060347511 @default.
• W4308708682 hasAuthorship W4308708682A5065469571 @default.
• W4308708682 hasAuthorship W4308708682A5068539599 @default.
• W4308708682 hasAuthorship W4308708682A5070548054 @default.
• W4308708682 hasAuthorship W4308708682A5077085879 @default.
• W4308708682 hasAuthorship W4308708682A5077135547 @default.
• W4308708682 hasAuthorship W4308708682A5077212270 @default.
• W4308708682 hasAuthorship W4308708682A5089685016 @default.
• W4308708682 hasBestOaLocation W43087086821 @default.
• W4308708682 hasConcept C126322002 @default.
• W4308708682 hasConcept C142724271 @default.
• W4308708682 hasConcept C204787440 @default.
• W4308708682 hasConcept C207103383 @default.
• W4308708682 hasConcept C27081682 @default.
• W4308708682 hasConcept C44249647 @default.
• W4308708682 hasConcept C50382708 @default.
• W4308708682 hasConcept C67761136 @default.
• W4308708682 hasConcept C71924100 @default.
• W4308708682 hasConceptScore W4308708682C126322002 @default.
• W4308708682 hasConceptScore W4308708682C142724271 @default.
• W4308708682 hasConceptScore W4308708682C204787440 @default.
• W4308708682 hasConceptScore W4308708682C207103383 @default.
• W4308708682 hasConceptScore W4308708682C27081682 @default.
• W4308708682 hasConceptScore W4308708682C44249647 @default.
• W4308708682 hasConceptScore W4308708682C50382708 @default.
• W4308708682 hasConceptScore W4308708682C67761136 @default.
• W4308708682 hasConceptScore W4308708682C71924100 @default.
• W4308708682 hasFunder F4320338282 @default.
• W4308708682 hasIssue "1" @default.
• W4308708682 hasLocation W43087086821 @default.
• W4308708682 hasLocation W43087086822 @default.
• W4308708682 hasLocation W43087086823 @default.
• W4308708682 hasOpenAccess W4308708682 @default.
• W4308708682 hasPrimaryLocation W43087086821 @default.
• W4308708682 hasRelatedWork W1770569162 @default.
• W4308708682 hasRelatedWork W2162310837 @default.
• W4308708682 hasRelatedWork W2728898687 @default.
• W4308708682 hasRelatedWork W2936672162 @default.
• W4308708682 hasRelatedWork W2994686985 @default.
• W4308708682 hasRelatedWork W3080371498 @default.
• W4308708682 hasRelatedWork W3158186989 @default.
• W4308708682 hasRelatedWork W4210693756 @default.
• W4308708682 hasRelatedWork W4233016836 @default.
• W4308708682 hasRelatedWork W4386591841 @default.
• W4308708682 hasVolume "9" @default.
• W4308708682 isParatext "false" @default.
• W4308708682 isRetracted "false" @default.

• next